About MDxHealth
MDxHealth is a leading molecular diagnostics company that develops and commercializes oncology based molecular diagnostic testing for personalized medicine. The company's tests are based on proprietary gene methylation technology and assist physicians and their patients with the accurate diagnosis of cancer, prognosis of recurrence risk and prediction of response to a specific therapy.
Advertisement
News about MDxHealth
Here you will find MDxHealth SA
Last viewed contents
Immunotope, Inc. - Doylestown PA, USA
Spin-off offers purification tool to tackle viral gene therapy manufacturing bottlenecks - Higher speed and increased yield thanks to membrane-based steric exclusion chromatography
One in six college students misuse ADHD stimulant drugs
NLS Pharma acquires a portfolio of strategic patents - Critical step in the novel development of a potential non-amphetaminic stimulant for ADHD
Herpes virus to be weaponized to fight cancer - Viral immunotherapy could also prove effective against metastases
New gene transporter to trick the immune system - Junior scientist receives 60.000 euro prize for research on haemophilia A therapy
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies - Ikarovec is developing novel gene therapies to treat serious, but common eye diseases
BioServe - Beltsville, USA
